Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_012536914.1 AFE_RS09350 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_000021485.1:WP_012536914.1 Length = 394 Score = 435 bits (1118), Expect = e-126 Identities = 233/390 (59%), Positives = 288/390 (73%), Gaps = 5/390 (1%) Query: 4 LGTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINMLD 63 LGT L +ATR++LLG+GELGKE+ I QRLGVE IAVDRYADAPAM VAHRSHV++M D Sbjct: 3 LGTPLSASATRLLLLGAGELGKELLIAAQRLGVETIAVDRYADAPAMQVAHRSHVLDMTD 62 Query: 64 GDALRRVVELEKPHYIVPEIEAIATDMLIQLEEEGL-NVVPCARATKLTMNREGIRRLAA 122 +A+ +V+ E+PHY+VPEIEAIAT L ++E +GL VVP ARA +LTM+REGIRRLAA Sbjct: 63 PEAILAIVKHERPHYVVPEIEAIATSALAEIEAKGLATVVPSARAVQLTMDREGIRRLAA 122 Query: 123 EELQLPTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYAQ 182 EEL LPTS YRFA + + +A A +G+PC++KPVMSSSGKGQ+ +R A +LA AW+ AQ Sbjct: 123 EELGLPTSPYRFAGTLAELEDAAAALGFPCVIKPVMSSSGKGQSVVRGAAELALAWQEAQ 182 Query: 183 QGGRAGAGRVIVEGVVKFDFEITLLTVSAVDGVHFCAPVGHRQEDGDYRESWQPQQMSPL 242 GR G R+IVEG V FDFEITLLTV + G FCAPVGHRQE GDY ESWQPQ MS Sbjct: 183 TAGRVGGQRIIVEGFVDFDFEITLLTVRSAFGTTFCAPVGHRQEAGDYVESWQPQPMSDT 242 Query: 243 ALERAQEIARKVVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDLSEFAL 302 AL A+++A++V LGG GL+GVE FV G EVIFSE+SPRPHDTG+VTL SQ SEF L Sbjct: 243 ALREAEKMAQRVTDNLGGRGLYGVEFFVRGTEVIFSELSPRPHDTGLVTLASQRQSEFDL 302 Query: 303 HVRAFLGLPV-GGIRQYGPAASAVILPQLTSQNVTFDNVQNAVGA-DLQIRLFGKPEIDG 360 H+RA LGLPV G R+ PAASAV+ + + ++ A+ + +RLFGKP Sbjct: 303 HLRAILGLPVEPGFRR--PAASAVVRGKRLGWGPVYSGLEVALAVPESDLRLFGKPTASK 360 Query: 361 SRRLGVALATAESVVDAIERAKHAAGQVKV 390 RRLGV +A A++V +A ERA+ A V + Sbjct: 361 LRRLGVGIACADNVEEARERARRIAAAVGI 390 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 451 Number of extensions: 14 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 394 Length adjustment: 31 Effective length of query: 361 Effective length of database: 363 Effective search space: 131043 Effective search space used: 131043 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory